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Radiotherapy (RT) is employed to achieve local cancer
control. However, in rare patients, regression of metastases
outside of the radiation field has been reported after irra-
diation of one tumor site, a phenomenon known as absco-
pal effect. We have previously shown in experimental
tumor models that the abscopal effect is mediated by acti-
vation of anti-tumor immune responses by radiotherapy,
which can convert the irradiated tumor into an in situ vac-
cine. However, effective induction of anti-tumor immunity
by radiation is rare. To study the barriers to the induction
of an abscopal effect we have employed a mouse model of
metastatic breast cancer. Ionizing radiation activates
Transforming Growth Factor-b (TGFb), a strongly immu-
nosuppressive cytokine that promotes DNA damage repair
(DDR) and metastasis. We therefore hypothesized that
neutralization of TGFb may improve the development of
anti-tumor immune responses induced by RT, leading to
an abscopal effect. To test this hypothesis, mouse mam-
mary carcinoma TSA cells were injected s.c. at day 0 into
syngeneic immunocompetent BALC/c mice at two sepa-
rate sites, a “primary” site that was irradiated, and a
secondary site outside of the radiation field. TGFb neutra-
lizing 1D11 mAb was given i.p. starting one day before
radiation. On day 12 when both tumors were palpable,
mice were randomly assigned to groups receiving either
1D11 mAb or isotype control (MOPC-21) every other day
for 16 days, with or without radiation (6 Gy doses given to
the primary tumor on days 13-17). Radiation alone effec-
tively delayed primary but not secondary tumor growth.
1D11 alone did not have a significant effect on either pri-
mary or secondary tumors. Combination of 1D11 with RT
enhanced significantly inhibition of the primary irradiated
tumor, with complete tumor regression in 4 out of 6 mice
by day 28 (p=0.0059 radiation+1D11 versus radiation).
Importantly, an abscopal effect was seen only in mice
treated with radiation + 1D11, with significantly smaller
secondary tumors on day 28 (p=0.0329 radiation+1D11
versus MOPC-21). Data indicate that blocking TGFb in
the context of radiation not only improves local tumor
control, but also induces an abscopal effect with systemic
tumor inhibition. Overall, data provide further support for
the use of agents targeting TGFb during radiotherapy, a
concept currently tested in a phase I/II clinical trial in
metastatic breast cancer patients (NCT01401062).
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